Sharon K. Rudolph

Pharmacokinetic-pharmacodynamic correlation from mouse to human with pazopanib, a multikinase angiogenesis inhibitor with potent antitumor and antiangiogenic activity

Rakesh Kumar, Victoria B. Knick, Sharon K. Rudolph et al. · Molecular Cancer Therapeutics · 2007 · 512 citations

Immunology, Pharmacotherapy, Bolus Administration +17

Discovery of 5-[[4-[(2,3-Dimethyl-2<i>H</i>-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide (Pazopanib), a Novel and Potent Vascular Endothelial Growth Factor Receptor Inhibitor

Philip A. Harris, Amogh Boloor, Mui Cheung et al. · Journal of Medicinal Chemistry · 2008 · 342 citations · Full text

Assessment of epidermal growth factor receptor (EGFR, ErbB1) and HER2 (ErbB2) protein expression levels and response to lapatinib (Tykerb^®, GW572016) in an expanded panel of human normal and tumour cell lines

David W. Rusnak, Krystal J. Alligood, Robert J. Mullin et al. · Cell Proliferation · 2007 · 174 citations · Full text

Generation and characterization of quinolone-specific DNA aptamers suitable for water monitoring

Christine Reinemann, U. Freiin von Fritsch, Sharon K. Rudolph et al. · Biosensors and Bioelectronics · 2015 · 119 citations

Nucleic Acid Chemistry, Bioorganic Chemistry, Engineering +13

High-Affinity Inhibitors of Dihydrofolate Reductase:  Antimicrobial and Anticancer Activities of 7,8-Dialkyl-1,3-diaminopyrrolo[3,2-<i>f</i>]quinazolines with Small Molecular Size

Lee F. Kuyper, David P. Baccanari, Michael L. Jones et al. · Journal of Medicinal Chemistry · 1996 · 106 citations · Full text